SI0758890T1 - - Google Patents

Info

Publication number
SI0758890T1
SI0758890T1 SI9530716T SI9530716T SI0758890T1 SI 0758890 T1 SI0758890 T1 SI 0758890T1 SI 9530716 T SI9530716 T SI 9530716T SI 9530716 T SI9530716 T SI 9530716T SI 0758890 T1 SI0758890 T1 SI 0758890T1
Authority
SI
Slovenia
Prior art keywords
migraine
scavenger
prophylactic
antagonist
inhibitor
Prior art date
Application number
SI9530716T
Other languages
English (en)
Inventor
Jes Olesen
Original Assignee
Jes Olesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jes Olesen filed Critical Jes Olesen
Publication of SI0758890T1 publication Critical patent/SI0758890T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
SI9530716T 1994-05-11 1995-05-10 SI0758890T1 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94610027 1994-05-11
EP95918128A EP0758890B1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine
PCT/IB1995/000415 WO1995031195A1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine

Publications (1)

Publication Number Publication Date
SI0758890T1 true SI0758890T1 (enExample) 2005-08-31

Family

ID=8218183

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530716T SI0758890T1 (enExample) 1994-05-11 1995-05-10

Country Status (12)

Country Link
US (1) US6265441B1 (enExample)
EP (1) EP0758890B1 (enExample)
JP (2) JPH10500129A (enExample)
AT (1) ATE291909T1 (enExample)
AU (1) AU704059B2 (enExample)
CA (1) CA2189762C (enExample)
DE (1) DE69534118T2 (enExample)
DK (1) DK0758890T3 (enExample)
ES (1) ES2238074T3 (enExample)
PT (1) PT758890E (enExample)
SI (1) SI0758890T1 (enExample)
WO (1) WO1995031195A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270531C (en) * 1996-11-05 2011-08-30 Head Explorer Aps A method for treating tension-type headache
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
AU1824300A (en) * 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1578413A2 (en) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
US20090191283A1 (en) * 2008-01-24 2009-07-30 Oronsky Bryan Todd Treatment of headaches, neck pain, joint pain and inflammatory-type pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2707494B1 (fr) 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
SK16396A3 (en) * 1993-08-12 1996-09-04 Astra Ab Amidine derivatives with nitric oxide synthetase activities
GB9317686D0 (en) 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
EP0759027B1 (en) * 1994-05-07 1999-08-04 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase

Also Published As

Publication number Publication date
EP0758890A1 (en) 1997-02-26
DK0758890T3 (da) 2005-04-18
US6265441B1 (en) 2001-07-24
AU704059B2 (en) 1999-04-15
JPH10500129A (ja) 1998-01-06
CA2189762A1 (en) 1995-11-23
CA2189762C (en) 2009-01-13
JP2007137906A (ja) 2007-06-07
AU2417995A (en) 1995-12-05
ES2238074T3 (es) 2005-08-16
DE69534118T2 (de) 2006-02-09
EP0758890B1 (en) 2005-03-30
DE69534118D1 (de) 2005-05-04
PT758890E (pt) 2005-06-30
ATE291909T1 (de) 2005-04-15
WO1995031195A1 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
GEP20074185B (en) Incclusion complexs of aryl- heterocyclic salts
PL316658A1 (en) Novel application of serotonin antagonists
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
NZ335981A (en) Ketobenzamides as calpain inhibitors
CA2180954A1 (en) Inhibitors of human plasmin derived from the kunitz domains
MY117798A (en) Use of a rapamycin derivative in vasculopathies and xenotransplantation
PL322549A1 (en) Inhibitors of proteinous farnesiltransferase
WO1999047131A3 (en) Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
SI0758890T1 (enExample)
TR200402670T4 (tr) Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
ZA981781B (en) The use of levobupivacaine in treating migraine
EP0858262A4 (en) THROMBIN INHIBITORS
BG102780A (en) Nasal application of agents for the treatment of delayed emesis fits
AP2003002855A0 (en) Inhibitor of monoamine uptake.
PT1303520E (pt) Compostos terapêuticos e métodos
HUT75529A (en) Use of dimeticone for treating constipation
ZA968444B (en) Methods of inhibiting plasminogen activator inhibitor 1.
GB9626472D0 (en) New use of comt inhibitors
TW340108B (en) 1,1-difluoro-1,4-dichlorobutane and process for its preparation
UA27780C2 (uk) Діюча речовина лікарського засобу для лікування або профілактики артеріосклерозу та/або асоційованих з ним серцево-судинних захворювань, спосіб лікування або профілактики артеріосклерозу у ссавців та лікарський засіб, що в ньому використовується
IL126157A0 (en) Method for treating excessive aggression
GR3019114T3 (en) Calcium borate/amino carboxylate corrosion inhibitors